Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.

Kliček, Robert and Kolenc, Danijela and Šuran, Jelena and Drmić, Domagoj and Brčić, Luka and Aralica, Gorana and Sever, Marko and Holjevac, J. and Radić, Božo and Turudić, Tanja and Kokot, A. and Patrlj, Leonardo and Rucman, Rudolf and Seiwerth, Sven and Sikirić, Predrag (2013) Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability. Journal of Physiology and Pharmacology, 64 (5). pp. 597-612. ISSN 0867-5910

[img]
Preview
PDF
Download (11MB) | Preview

Abstract

Stable gastric pentadecapeptide BPC 157 was suggested to link inflammatory bowel disease and multiple sclerosis, and thereby, shown to equally counteract the models of both of those diseases. For colitis, cysteamine (400 mg/kg intrarectally (1 ml/rat)) and colon-colon anastomosis (sacrifice at day 3, 5, 7, and 14) were used. BPC 157 (10 μg/kg, 10 ng/kg) was applied either intraperitoneally once time daily (first application immediately after surgery, last at 24 hours before sacrifice) or per-orally in drinking water (0.16 μg/ml/12 ml/day till the sacrifice) while controls simultaneously received an equivolume of saline (5 ml/kg) intraperitoneally or drinking water only (12 ml/day). A multiple sclerosis suited toxic rat model, cuprizone (compared with standard, a several times higher regimen, 2.5% of diet regimen + 1 g/kg intragastrically/day) was combined with BPC 157 (in drinking water 0.16 μg or 0.16 ng/ml/12 ml/day/rat + 10 μg or 10 ng/kg intragastrically/day) till the sacrifice at day 4. In general, the controls could not heal cysteamine colitis and colon-colon anastomosis. BPC 157 induced an efficient healing of both at the same time. Likewise, cuprizone-controls clearly exhibited an exaggerated and accelerated damaging process; nerve damage appeared in various brain areas, with most prominent damage in corpus callosum, laterodorsal thalamus, nucleus reunions, anterior horn motor neurons. BPC 157-cuprizone rats had consistently less nerve damage in all damaged areas, especially in those areas that otherwise were most affected. Consistently, BPC 157 counteracted cerebellar ataxia and impaired forelimb function. Thereby, this experimental evidence advocates BPC 157 in both inflammatory bowel disease and multiple sclerosis therapy.

Item Type: Article
Departments: Katedra za farmakologiju
Katedra za patologiju
Depositing User: Marijan Šember
Status: Published
Creators:
CreatorsEmail
Kliček, RobertUNSPECIFIED
Kolenc, DanijelaUNSPECIFIED
Šuran, JelenaUNSPECIFIED
Drmić, DomagojUNSPECIFIED
Brčić, LukaUNSPECIFIED
Aralica, GoranaUNSPECIFIED
Sever, MarkoUNSPECIFIED
Holjevac, J.UNSPECIFIED
Radić, BožoUNSPECIFIED
Turudić, TanjaUNSPECIFIED
Kokot, A.UNSPECIFIED
Patrlj, LeonardoUNSPECIFIED
Rucman, RudolfUNSPECIFIED
Seiwerth, SvenUNSPECIFIED
Sikirić, PredragUNSPECIFIED
Date: October 2013
Date Deposited: 13 Feb 2014 09:01
Last Modified: 13 Feb 2014 09:01
Subjects: /
Related URLs:
URI: http://medlib.mef.hr/id/eprint/2044

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year